Swedish Specialty Pharma Meda Acquires MedPointe In $800 Million Transaction
This article was originally published in The Pink Sheet Daily
Executive Summary
Meda also acquires MedPointe’s 500-strong U.S. sales force in the deal.
You may also be interested in...
Orexo Files NDA For Dissolving Zolpidem
Payers likely to favor generic Ambien for short-term insomnia, analyst tells “The Pink Sheet” DAILY.
Orexo Files NDA For Dissolving Zolpidem
Payers likely to favor generic Ambien for short-term insomnia, analyst tells “The Pink Sheet” DAILY.
BioDelivery Files BEMA Fentanyl NDA For Breakthrough Cancer Pain
Commercial partner Meda has 450 specialty reps at the ready for late 2008 launch of the fast-dissolving buccal pain therapy, BDSI CEO Sirgo says.